Rubric Capital Management LP
13F Reported Value
ⓘ$9.4B
incl. option notional
Equity Holdings
ⓘ$8.2B
Option Notional
ⓘ$1.3B
$1.3B puts / $0 calls
Holdings
83
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Rubric Capital Management LP disclosed 83 positions worth $9.4B in its Form 13F-HR for Q1 2026 — $8.2B in common stock plus $1.3B of put/call option positions (reported at underlying notional value, not premium at risk), followed by $TLN and $FTAI. During the quarter the fund opened 16 new positions and exited 9 and a full exit from $FLR. The portfolio is most concentrated in Healthcare (32.9% of disclosed assets). All figures are sourced directly from Rubric Capital Management LP’s Form 13F-HR filing with the SEC under CIK 1687509.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
ISHARES TR PUT
—Quality
$1.3B5,150,000 sh- 66.5#516
Quality
$1.1B3,602,171 sh - —
Quality
$631.2M2,576,186 sh - —
Quality
$496.7M9,178,978 sh - $459.3M15,250,000 sh
- 47.1
Quality
$452.6M33,500,000 sh - —
Quality
$232.9M17,781,325 sh - 69.9
Quality
$227.9M23,300,000 sh - 62.9
Quality
$225.5M1,500,000 sh - 62.5
Quality
$199.7M715,000 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| ISHARES TR PUT | — | $1.3B | 5,150,000 |
 Talen Energy Corp$TLN | 66.5#516 | $1.1B | 3,602,171 |
 FTAI Aviation Ltd.$FTAI | — | $631.2M | 2,576,186 |
 GOLAR LNG LTD$GLNG | — | $496.7M | 9,178,978 |
 TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA | — | $459.3M | 15,250,000 |
 Viatris Inc$VTRS | 47.1 | $452.6M | 33,500,000 |
 TRANSALTA CORP$TAC | — | $232.9M | 17,781,325 |
 BGC Group, Inc.$BGC | 69.9 | $227.9M | 23,300,000 |
 Vistra Corp.$VST | 62.9 | $225.5M | 1,500,000 |
 Constellation Energy Corp$CEG | 62.5 | $199.7M | 715,000 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Rubric Capital Management LP's 83 positions.
Showing top 10 of 83 holdings.
Sector Allocation
Healthcare
$2.7B
Utilities
$1.9B
Industrials
$1.4B
Communication Services
$761.4M
Financials
$422.6M
Consumer Staples
$259.5M
Consumer Discretionary
$234.6M
Technology
$209.1M
Full Holdings — Rubric Capital Management LP (Q1 2026)
All 83 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | — | ISHARES TR | $1.3B | — | NEW | — |
| 2 | $TLN | Talen Energy Corp | $1.1B | 14.1% | +0% | 66.5 |
| 3 | $FTAI | FTAI Aviation Ltd. | $631.2M | 7.7% | -30% | — |
| 4 | $GLNG | GOLAR LNG LTD | $496.7M | 6.1% | +0% | — |
| 5 | $TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $459.3M | 5.6% | -29% | — |
| 6 | $VTRS | Viatris Inc | $452.6M | 5.5% | +31% | 47.1 |
| 7 | $TAC | TRANSALTA CORP | $232.9M | 2.9% | +0% | — |
| 8 | $BGC | BGC Group, Inc. | $227.9M | 2.8% | +11% | 69.9 |
| 9 | $VST | Vistra Corp. | $225.5M | 2.8% | -25% | 62.9 |
| 10 | $CEG | Constellation Energy Corp | $199.7M | 2.5% | +7% | 62.5 |
| 11 |  $ARQT | Arcutis Biotherapeutics, Inc. | $194.9M | 2.4% | +0% | 41.2 |
| 12 |  $MCY | MERCURY GENERAL CORP | $189.9M | 2.3% | +5% | 70.4 |
| 13 |  $KNSA | Kiniksa Pharmaceuticals International, plc | $180.6M | 2.2% | +13% | — |
| 14 |  $ZYME | Zymeworks Inc. | $175.3M | 2.1% | +22% | 27.2 |
| 15 |  $AKAM | AKAMAI TECHNOLOGIES INC | $149.3M | 1.8% | +8% | 62 |
| 16 |  $LBTYA | Liberty Global Ltd. | $142.1M | 1.7% | +17% | — |
| 17 |  $ROIV | Roivant Sciences Ltd. | $138.5M | 1.7% | -44% | — |
| 18 |  $AMRX | Amneal Pharmaceuticals, Inc. | $137.2M | 1.7% | -11% | 58.9 |
| 19 |  $LILA | Liberty Latin America Ltd. | $135.8M | 1.7% | +44% | — |
| 20 |  $DK | Delek US Holdings, Inc. | $121.1M | 1.5% | +0% | 33.9 |
| 21 |  $CMPR | CIMPRESS plc | $118.9M | 1.5% | +7% | — |
| 22 |  $ECVT | Ecovyst Inc. | $117.5M | 1.4% | -13% | 36.6 |
| 23 | $LBTYA | Liberty Global Ltd. | $108.6M | 1.3% | +51% | — |
| 24 |  $ADEA | Adeia Inc. | $102.9M | 1.3% | +0% | 57.6 |
| 25 |  $EPC | EDGEWELL PERSONAL CARE Co | $85.4M | 1.1% | +297% | 36.8 |
| 26 |  $ZM | Zoom Communications, Inc. | $80.5M | 1.0% | NEW | 72.4 |
| 27 |  $TDS | TELEPHONE & DATA SYSTEMS INC /DE/ | $77.9M | 0.9% | +0% | 42.2 |
| 28 |  $GIL | Gildan Activewear Inc. | $77.7M | 0.9% | +444% | — |
| 29 |  $IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $73.0M | 0.9% | +0% | 31.7 |
| 30 |  $SDGR | Schrodinger, Inc. | $68.2M | 0.8% | +44% | 31 |
| 31 |  $SPRY | ARS Pharmaceuticals, Inc. | $64.2M | 0.8% | +29% | 29.7 |
| 32 |  $GEO | GEO GROUP INC | $62.9M | 0.8% | +7% | 63 |
| 33 |  $SSYS | STRATASYS LTD. | $62.5M | 0.8% | +9% | — |
| 34 |  $ANDE | Andersons, Inc. | $61.4M | 0.8% | -15% | 39.7 |
| 35 |  $MGTX | MeiraGTx Holdings plc | $60.6M | 0.7% | +13% | — |
| 36 |  $ENOV | Enovis CORP | $55.8M | 0.7% | +0% | 40.5 |
| 37 |  $OPK | OPKO HEALTH, INC. | $54.5M | 0.7% | +0% | 20 |
| 38 |  $QDEL | QuidelOrtho Corp | $54.3M | 0.7% | -12% | 26.4 |
| 39 |  $PRMB | Primo Brands Corp | $52.4M | 0.6% | -23% | 46.5 |
| 40 |  $NWL | NEWELL BRANDS INC. | $52.3M | 0.6% | +17% | 41.3 |
| 41 |  $AMCR | Amcor plc | $50.5M | 0.6% | NEW | — |
| 42 |  $RNW | ReNew Energy Global plc | $50.4M | 0.6% | +0% | — |
| 43 | — | PROTHENA CORP PLC | $48.6M | 0.6% | +36% | — |
| 44 |  $PTGX | Protagonist Therapeutics, Inc | $45.1M | 0.6% | NEW | 24.8 |
| 45 |  $TRVI | Trevi Therapeutics, Inc. | $44.3M | 0.5% | -1% | — |
| 46 |  $OFIX | Orthofix Medical Inc. | $42.7M | 0.5% | +0% | 32.9 |
| 47 |  $COLL | COLLEGIUM PHARMACEUTICAL, INC | $42.3M | 0.5% | -14% | 60.8 |
| 48 |  $CXW | CoreCivic, Inc. | $38.9M | 0.5% | +5% | 59 |
| 49 |  $NRIX | Nurix Therapeutics, Inc. | $38.3M | 0.5% | +0% | 13.2 |
| 50 |  $DRVN | Driven Brands Holdings Inc. | $37.8M | 0.5% | NEW | 52.8 |
| 51 |  $CVGW | CALAVO GROWERS INC | $36.5M | 0.5% | NEW | 54.6 |
| 52 |  $CRI | CARTERS INC | $36.4M | 0.5% | +121% | 37.8 |
| 53 |  $VISN | Vistance Networks, Inc. | $36.4M | 0.5% | NEW | 43.9 |
| 54 |  $MATV | Mativ Holdings, Inc. | $34.6M | 0.4% | +0% | 33.4 |
| 55 | $LILA | Liberty Latin America Ltd. | $32.4M | 0.4% | +93% | — |
| 56 |  $TSAT | Telesat Corp | $30.5M | 0.4% | +0% | — |
| 57 |  $ABUS | Arbutus Biopharma Corp | $29.8M | 0.4% | +321% | — |
| 58 |  $PRLB | Proto Labs Inc | $27.7M | 0.3% | -57% | 51.2 |
| 59 |  $COMP | Compass, Inc. | $27.4M | 0.3% | -46% | 58.3 |
| 60 |  $BMRN | BIOMARIN PHARMACEUTICAL INC | $24.9M | 0.3% | NEW | 74.1 |
| 61 |  $HRTX | HERON THERAPEUTICS, INC. /DE/ | $24.0M | 0.3% | +0% | 30.6 |
| 62 |  $AVO | Mission Produce, Inc. | $23.8M | 0.3% | NEW | 50.5 |
| 63 |  $VG | Venture Global, Inc. | $23.6M | 0.3% | NEW | 69 |
| 64 |  $XPER | Xperi Inc. | $23.2M | 0.3% | +0% | 25.1 |
| 65 |  $TH | Target Hospitality Corp. | $20.3M | 0.3% | +0% | 29.5 |
| 66 |  $INDV | Indivior Pharmaceuticals, Inc. | $20.2M | 0.3% | +33% | 64.6 |
| 67 |  $ACHC | Acadia Healthcare Company, Inc. | $19.9M | 0.2% | +0% | 49.3 |
| 68 |  $ADMA | ADMA BIOLOGICS, INC. | $16.3M | 0.2% | NEW | 76 |
| 69 |  $DNOW | DNOW Inc. | $15.1M | 0.2% | NEW | 49.6 |
| 70 |  $SEG | Seaport Entertainment Group Inc. | $12.2M | 0.1% | +0% | 13.3 |
| 71 |  $CPRI | Capri Holdings Ltd | $11.9M | 0.1% | +0% | — |
| 72 |  $ARDX | ARDELYX, INC. | $11.1M | 0.1% | NEW | 35.3 |
| 73 |  $EMBC | Embecta Corp. | $9.2M | 0.1% | +0% | 60.2 |
| 74 |  $MNKD | MANNKIND CORP | $8.9M | 0.1% | -52% | 44.4 |
| 75 |  $AERO | Grupo Aeromexico, S.A.B. de C.V. | $6.5M | 0.1% | NEW | — |
| 76 |  $HELE | HELEN OF TROY LTD | $5.3M | 0.1% | +43% | 34.9 |
| 77 |  $MREO | Mereo BioPharma Group plc | $5.1M | 0.1% | +0% | — |
| 78 |  $EPRX | EUPRAXIA PHARMACEUTICALS INC. | $5.0M | 0.1% | NEW | — |
| 79 |  $PFSI | PennyMac Financial Services, Inc. | $4.8M | 0.1% | NEW | 54.2 |
| 80 |  $EDSA | Edesa Biotech, Inc. | $3.6M | 0.0% | +0% | — |
| 81 |  $TXMD | TherapeuticsMD, Inc. | $2.4M | 0.0% | +0% | — |
| 82 | $OPK | OPKO HEALTH, INC. | $1.5M | 0.0% | +0% | 20 |
| 83 |  $MYPS | PLAYSTUDIOS, Inc. | $1.3M | 0.0% | +0% | 28.7 |
New Positions (16)
$ZM Zoom Communications, Inc.$80.5M$AMCR Amcor plc$50.5M$PTGX Protagonist Therapeutics, Inc$45.1M$DRVN Driven Brands Holdings Inc.$37.8M$CVGW CALAVO GROWERS INC$36.5M$VISN Vistance Networks, Inc.$36.4M$BMRN BIOMARIN PHARMACEUTICAL INC$24.9M$AVO Mission Produce, Inc.$23.8M$VG Venture Global, Inc.$23.6M$ADMA ADMA BIOLOGICS, INC.$16.3M$DNOW DNOW Inc.$15.1M$ARDX ARDELYX, INC.$11.1M$AERO Grupo Aeromexico, S.A.B. de C.V.$6.5M$EPRX EUPRAXIA PHARMACEUTICALS INC.$5.0M
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Rubric Capital Management LP including:
Track Rubric Capital Management LP's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Rubric Capital Management LP and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Rubric Capital Management LP
13F Pro is an AI hedge fund tracker and stock research platform. For Rubric Capital Management LP (SEC CIK: 1687509), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Rubric Capital Management LP's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.